Callewaert; Nico

Patent Applications and Registrations

Patent applications and USPTO patent grants for Callewaert; Nico.The latest application filed is for "means and methods for single molecule peptide sequencing".

Company Profile

10.7.16

Callewaert; Nico - Nevele BE
Callewaert; Nico - Deinze BE
- Nevele BE
Callewaert; Nico - Nevele-Hansbeke N/A BE
Callewaert, Nico - Lichtervelde BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Means And Methods For Single Molecule Peptide Sequencing App 20220214354 - Callewaert; Nico ; et al.	2022-07-07
Cells producing glycoproteins having altered N- and O-glycosylation patterns and methods and use thereof Grant 11,293,012 - Callewaert , et al. April 5, 2	2022-04-05
Compositions For Active Immunotherapy App 20210261604 - Callewaert; Nico ; et al.	2021-08-26
Compositions For Use To Treat Cataract App 20210030780 - Van Aken; Elisabeth ; et al.	2021-02-04
Means and Methods for the Production of Terpenoids App 20200385762 - Goossens; Alain ; et al.	2020-12-10
Genetically Engineered Eukaryotic Cells Producing Sialylated Glycoproteins App 20200277641 - Callewaert; Nico ; et al.	2020-09-03
Means and methods for amplifying nucleotide sequences Grant 10,752,943 - Callewaert , et al. A	2020-08-25
Genetically Engineered Eukaryotic Cells Producing Lacnac-glycoproteins App 20200255878A1 -	2020-08-13
Means And Methods For Single Molecule Peptide Sequencing App 20200231956 - Callewaert; Nico ; et al.	2020-07-23
Glycosylation Of Variable Immunoglobulin Domains App 20200148790 - Callewaert; Nico ; et al.	2020-05-14
Means And Methods For Oral Protein Delivery App 20200009229 - Callewaert; Nico ; et al.	2020-01-09
Means And Methods For Amplifying Nucleotide Sequences App 20190048412 - Callewaert; Nico ; et al.	2019-02-14
Cells Producing Glycoproteins Having Altered N- And O-glycosylationpatterns And Methods And Use Thereof App 20180187177 - Callewaert; Nico ; et al.	2018-07-05
Tools and methods for expression of membrane proteins Grant 9,890,217 - Steyaert , et al. February 13, 2	2018-02-13
Tools And Methods For Expression Of Membrane Proteins App 20140357521 - Steyaert; Jan ; et al.	2014-12-04
Mycobacterium mutants for vaccines with improved protective efficacy Grant 8,685,415 - Callewaert , et al. April 1, 2	2014-04-01
Nucleic acids of Pichia pastoris and use thereof for recombinant production of proteins Grant 8,440,456 - Callewaert , et al. May 14, 2	2013-05-14
Mycobacterium Mutants For Vaccines With Improved Protective Efficacy App 20120128720 - Callewaert; Nico ; et al.	2012-05-24
Methods For Producing Substantially Homogeneous Hybrid Or Complex N-glycans In Methylotrophic Yeasts App 20120029174 - Callewaert; Nico ; et al.	2012-02-02
Methods For Producing Substantially Homogeneous Hybrid Or Complex N-glycans In Methylotrophic Yeasts App 20110092374 - Callewaert; Nico ; et al.	2011-04-21
Nucleic Acids Of Pichia Pastoris And Use Thereof For Recombinant Production Of Proteins App 20110021378 - Callewaert; Nico ; et al.	2011-01-27
High level protein expression system App 20040029229 - Reeves, Philip J. ; et al.	2004-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.